Analyst Ratings for Avita Medical Ltd. (RCEL)
RCEL Rating Summary
RCEL Price Target Summary
- Highest: $14.00 (D. Boral Capital)
- Lowest: $3.50 (Lake Street )
- Average: $9.63
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.63 (+102.6%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
Avg. $ Target:
$9.63 (+102.6%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Northland | Carl Byrnes Jr. | New Coverage | Outperform (N/A) |
10.00 (N/A) |
4.96 (4.75) |
-4.23% | Details |
| 11/20/2025 | BTIG | Ryan Zimmerman | Upgrade | Neutral (Sell) |
N/A (N/A) |
3.95 (4.75) |
20.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
